Title: The cost utility of autologous chondrocytes implantation using ChondroCelect® in symptomatic knee cartilage lesions in Belgium
Authors: Gerlier, Laetitia ×
Lamotte, Mark
Wille, Micheline
Kreuz, Peter C
Vanlauwe, Johan
Dubois, Dominique
Meurgey, François M #
Issue Date: Dec-2010
Publisher: Adis International
Series Title: Pharmacoeconomics vol:28 issue:12 pages:1129-46
Article number: 10.2165/11584920-000000000-00000
Abstract: Knee cartilage lesions increase the risk of developing osteoarthritis (OA), and may eventually result in a total knee replacement (TKR). There is currently no consensus on the optimal treatment of cartilage lesions. ChondroCelect® (CC) is a cell-based therapy approved for use in autologous chondrocytes implantation (ACI) to treat symptomatic cartilage defects of the femoral condyle. Its capacity to safely restore good-quality cartilage was demonstrated in a randomized controlled trial (RCT) versus the surgical procedure microfracture (MFX).
ISSN: 1170-7690
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Orthopaedics Section (-)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science